Virbac S.A. (VIRP.PA) Stock Analysis & Winston Score

Virbac is a French company that makes medicines and health products for animals. Its main products include vaccines, anti-parasite treatments, dental care, and nutrition supplements for pets like dogs and cats, as well as farm animals like cattle and fish. Virbac sells to veterinarians, farmers, and pet owners, making it one of the largest companies in the world focused entirely on animal health. Virbac earns money by selling its products directly to vets and through distributors across more than 100 countries, with strong presence in Europe, Latin America, Asia-Pacific, and North America. Its focus on animal health only — rather than splitting attention between human and animal drugs like larger rivals — gives it a specialized edge, though it competes against much bigger companies like Zoetis and Elanco that have greater resources. The key growth driver is rising pet ownership globally, while the main risk is pricing pressure and competition from generic animal medicines.